SII

The delegates noted the critical role played by the US-India cooperation in addressing the COVID-19 pandemic and other global…

Poonawalla is learnt to have briefed Union Health Minister Mansukh Mandaviya on the subject during a meeting at the Nirman Bhawan…

The government advisory panel NTAGI recently is learnt to have also approved the qHPV after reviewing the clinical trial data of…

Amid rising cases of coronavirus in the country, the government started providing precaution doses free of cost to those aged 18…

The expert panel in its last meeting in April had sought more data from SII following its application seeking the Emergency Use…

The firm has applied for market authorisation after completing the phase-II/III clinical trial with support of the Department of…

Dr Poonawalla has been felicitated with Dean’s medal for his life-long contribution with this honour, reserved for luminaries…

The firm will soon seek market authorisation as well as a manufacturing licence from the Drugs Controller General of India (DCGI)…

The MoU will see both the entities work towards promoting research and innovation to increase impact of vaccines, technologies and…

The firm is reducing the price of each dose from Rs 900 to Rs 225 plus Goods and Services Tax (GST) for private hospitals. In…